November 9, 2025
Gate2chain to join nChain as we redefine the Peer-to-Peer economy. nChain has acquired 20% of Gate2Chain and established a strategic partnership to drive mass adoption of its product suite Gate2chain to join nChain as we redefine the Peer-to-Peer economy. nChain has acquired 20% of Gate2Chain and established a strategic partnership to drive mass adoption of its product suite
1 min read

Gate2chain to join nChain as we redefine the Peer-to-Peer economy. nChain has acquired 20% of Gate2Chain and established a strategic partnership to drive mass adoption of its product suite

Jonathan Jeriah April 26, 2023
The partnership with nChain provides security and legal certainty in enforcing IP rights to...
Read More

You may have missed

Sydney Sweeney Has Abandoned Her Jeans Sydney Sweeney Has Abandoned Her Jeans

Sydney Sweeney Has Abandoned Her Jeans

November 9, 2025
12 Must-Watch Comedy Movies on Netflix Right Now (September 2025) 12 Must-Watch Comedy Movies on Netflix Right Now (September 2025)

12 Must-Watch Comedy Movies on Netflix Right Now (September 2025)

November 9, 2025
Democrats: Don’t Let Trump Define What State Capitalism Can Be Democrats: Don’t Let Trump Define What State Capitalism Can Be

Democrats: Don’t Let Trump Define What State Capitalism Can Be

November 9, 2025
Is it legal for President Trump to rename the Department of Defense the Department of War? Is it legal for President Trump to rename the Department of Defense the Department of War?

Is it legal for President Trump to rename the Department of Defense the Department of War?

November 9, 2025
JACK POSOBIEC and SEN BERNIE MORENO: Tax foreign call centers to create American jobs and benefit consumers JACK POSOBIEC and SEN BERNIE MORENO: Tax foreign call centers to create American jobs and benefit consumers

JACK POSOBIEC and SEN BERNIE MORENO: Tax foreign call centers to create American jobs and benefit consumers

November 9, 2025
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

November 9, 2025